
PAGAN ELEONORA
- U07, Piano: 4, Stanza: 4059
Pubblicazioni
Vicini, E., Galimberti, V., Leonardi, M., Kahler-Ribeiro-Fontana, S., Polizzi, A., Petitto, S., et al. (2025). Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients. BREAST CANCER RESEARCH AND TREATMENT, 210(3), 661-672 [10.1007/s10549-024-07604-3]. Dettaglio
Conforti, F., Nekljudova, V., Sala, I., Ascari, R., Solbach, C., Untch, M., et al. (2025). Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer. JOURNAL OF CLINICAL ONCOLOGY, 43(12), 1441-1452 [10.1200/JCO-24-01360]. Dettaglio
Peradze, N., Polizzi, A., Pagan, E., Bottazzoli, E., Bagnardi, V., Sangalli, C., et al. (2025). Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 51(6 (June 2025)) [10.1016/j.ejso.2025.109714]. Dettaglio
Pala, L., Merlo, F., Sala, I., Pagan, E., Oriecuia, C., Specchia, C., et al. (2025). Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates. JOURNAL OF THE NATIONAL CANCER INSTITUTE [10.1093/jnci/djaf049]. Dettaglio
Sala, I., Pagan, E., Pala, L., Oriecuia, C., Musca, M., Specchia, C., et al. (2024). Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis. FRONTIERS IN IMMUNOLOGY, 15 [10.3389/fimmu.2024.1340979]. Dettaglio
Premi e responsabilità scientifiche
Premi
- Premio Giovani Talenti, Università degli Studi di Milano Bicocca con il Patrocinio dell’Accademia Nazionale dei Lincei, 2022
- Premio Gabriella Serio, Società Italiana di Statistica Medica ed Epidemiologia Clinica (SISMEC), 2021